Cite
HARVARD Citation
Wu, X. et al. (2018). PI3K/AKT/mTOR pathway inhibitors inhibit the growth of melanoma cells with mTOR H2189Y mutations in vitro. Cancer biology & therapy. 19 (7), pp. 584-589. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wu, X. et al. (2018). PI3K/AKT/mTOR pathway inhibitors inhibit the growth of melanoma cells with mTOR H2189Y mutations in vitro. Cancer biology & therapy. 19 (7), pp. 584-589. [Online].